We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.94B
AUM Growth
-$6.24M
Cap. Flow
-$8.36M
Cap. Flow %
-0.43%
Top 10 Hldgs %
18.4%
Holding
264
New
14
Increased
88
Reduced
101
Closed
15

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$20.5M
2
CELH icon
Celsius Holdings
CELH
+$20M
3
AHCO icon
AdaptHealth
AHCO
+$19.3M
4
NOG icon
Northern Oil and Gas
NOG
+$18.9M
5
PRVA icon
Privia Health
PRVA
+$16.5M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$24.9M
2
AVNT icon
Avient
AVNT
+$21.7M
3
ONTO icon
Onto Innovation
ONTO
+$20M
4
ALKS icon
Alkermes
ALKS
+$19.3M
5
VC icon
Visteon
VC
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 30.67%
2 Industrials 16.05%
3 Consumer Discretionary 13.81%
4 Technology 13.49%
5 Financials 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EE icon
51
Excelerate Energy
EE
$1.24B
$16.2M 0.84%
693,905
+91,247
+15% +$2.16M
ONT
52
Onterris Inc
ONT
$756M
$16M 0.83%
476,549
+138
+0% +$5.47K
CUBI icon
53
Customers Bancorp
CUBI
$2.65B
$15.8M 0.82%
536,165
– –
WOOF icon
54
Petco
WOOF
$760M
$15.3M 0.79%
1,371,638
+10,929
+0.8% +$160K
PRVA icon
55
Privia Health
PRVA
$3.39B
$15.2M 0.78%
+446,454
New +$16.5M
ANIP icon
56
ANI Pharmaceuticals
ANIP
$1.8B
$14.7M 0.76%
456,748
+868
+0.2% +$29.7K
PTLO icon
57
Portillo's
PTLO
$338M
$14.6M 0.75%
741,124
+280,291
+61% +$6.17M
RARE icon
58
Ultragenyx Pharmaceutical
RARE
$2.88B
$14.4M 0.74%
347,081
+145,864
+72% +$7.5M
TNDM icon
59
Tandem Diabetes Care
TNDM
$1.17B
$14.3M 0.74%
298,210
-102,721
-26% -$5.63M
ARVN icon
60
Arvinas
ARVN
$517M
$14.2M 0.73%
319,737
+51,481
+19% +$2.5M
FA icon
61
First Advantage
FA
$3.83B
$13.9M 0.72%
1,080,900
-35,310
-3% -$491K
HLI icon
62
Houlihan Lokey
HLI
$9.67B
$13.8M 0.71%
183,700
-2,498
-1% -$202K
VIAV icon
63
Viavi Solutions
VIAV
$9.41B
$13.8M 0.71%
1,057,876
-217,506
-17% -$3.1M
HRI icon
64
Herc Holdings
HRI
$4.99B
$13.7M 0.71%
131,850
-145
-0.1% -$16.1K
RETA
65
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$13.5M 0.7%
538,252
+252,071
+88% +$6.99M
VC icon
66
Visteon
VC
$2.8B
$13.3M 0.68%
125,087
-133,012
-52% -$15.9M
COLL icon
67
Collegium Pharmaceutical
COLL
$1.17B
$13.1M 0.68%
817,149
+4,671
+0.6% +$82.4K
CCOI icon
68
Cogent Communications
CCOI
$549M
$13.1M 0.67%
250,669
– –
HRT
69
DELISTED
HireRight Holdings Corporation
HRT
$12.9M 0.66%
844,583
-249
-0% -$3.94K
BJRI icon
70
BJ's Restaurants
BJRI
$1.42B
$12.9M 0.66%
540,176
+123,930
+30% +$3.05M
ARIS
71
DELISTED
Aris Water Solutions
ARIS
$12.9M 0.66%
1,008,154
+166,618
+20% +$2.85M
IMGO
72
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$12.8M 0.66%
853,637
+30,575
+4% +$496K
AMRC icon
73
Ameresco
AMRC
$1.22B
$12.6M 0.65%
189,959
+30
+0% +$1.84K
TTI icon
74
TETRA Technologies
TTI
$1.37B
$12.2M 0.63%
3,388,720
+1,423,300
+72% +$5.61M
MNKD icon
75
MannKind Corp
MNKD
$1.25B
$11.6M 0.6%
3,765,284
-1,230,197
-25% -$4.64M
1 2
3
4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, Emerald Advisers held 264 positions worth $1.94B, down 0.32% from $1.94B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers's Q3 2022 filing shows 14 new, 88 increased, 101 reduced and 15 closed positions. Its largest new stake was Blueprint Medicines: 318,574 shares worth $21M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $24.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Emerald Advisers's largest Q3 2022 buy was Blueprint Medicines: 318,574 shares worth $21M.
  • Emerald Advisers added most to AdaptHealth in Q3 2022, an estimated $19.3M increase.
  • Emerald Advisers's biggest Q3 2022 reduction was Avient, cutting an estimated $21.7M.
  • Emerald Advisers fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $24.9M.
  • Emerald Advisers's ten largest holdings make up 18% of its $1.94B portfolio in Q3 2022.
  • Emerald Advisers opened 14 new positions and closed 15 in Q3 2022.
  • Emerald Advisers's portfolio value fell 0.32% quarter-over-quarter to $1.94B.

Based on Emerald Advisers's 13F filing for Q3 2022, filed 25 Oct 2022.